INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 31 December 2011
|
Total net assets |
£102.8m |
|
NAV per share |
185.0p |
|
Share price |
159.0p |
|
Total value of unquoted investments |
£17.9m |
|
Total number of portfolio companies |
69 |
|
Cash |
3% NAV |
|
Cash committed and reserved to unquoted investments |
(9)% NAV |
|
Portfolio companies with < 1 year of cash |
13.3% NAV |
Top Ten Holdings
|
Company Name |
% NAV |
|
Gilead Sciences |
5.6 |
|
Amgen |
5.4 |
|
Micromet |
4.7 |
|
Teva |
4.2 |
|
Insulet |
4.1 |
|
Pharmaxis |
3.5 |
|
Celgene |
3.3 |
|
Shire |
2.9 |
|
Alexion |
2.9 |
|
EUSA |
2.9 |
|
|
----------- |
|
Total |
39.5 |
|
Geographical Allocation |
% |
|
United States |
73 |
|
Europe |
15 |
|
Israel |
5 |
|
Australia |
4 |
|
Cash |
3 |
|
|
----------- |
|
Total |
100 |
|
Quoted/Unquoted allocation |
% |
|
Quoted |
80 |
|
Unquoted |
17 |
|
Cash |
3 |
|
|
----------- |
|
Total |
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
23 JANUARY 2012